Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$804.0M
Avg Funding
$32.2M
Global Reach
7
countries

Top Cities for Biopharma

Montefiascone
Vancouver
Austin
Boston
Metairie
Carlsbad

Recently Funded Companies

Export
Montefiascone, Italy

GeneSys Bio's portable AI system detects pathogens and AMR in < 30 mins with >98% sensitivity, replacing slow lab tests and saving lives.

$107K raised
Jun 2024

Founder Contacts

30,000+ verified contacts

Vancouver, United States

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

$100.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Austin, United States

Ollin Biosciences develops ophthalmic therapies focused on treating serious vision-threatening diseases.

$330.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Boston, United States

Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs.

$12.6M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Metairie, United States

28bio is a neurotechnology company that develops brain-on-a-chip platform designed to capture neurological processes.

$6.5M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Carlsbad, United States

Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health and dermatological conditions.

$20.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Boston, United States

Viron is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid is under FDA review.

$6.0M raised
Jun 2022

Founder Contacts

30,000+ verified contacts

San Francisco, United States

Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.

$1.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Daix, France

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

$120.0M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Victoria, Canada

Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.

$3.1M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

New York, United States

MiNK Therapeutics is a biopharmaceutical company developing allogeneic iNKT cell therapies and immune technologies for treatment.

Jun 2025

Founder Contacts

30,000+ verified contacts

Boston, United States

Vibe Bio is an AI-based life sciences company that helps biopharma companies with analysis and strategic drug pipeline decisions.

$12.0M raised
Jun 2022

Founder Contacts

30,000+ verified contacts

San Francisco, United States

LatchBio is a biotech research company that provides code-free platform for the biocomputing revolution.

$28.0M raised
Jun 2022

Founder Contacts

30,000+ verified contacts

Los Angeles, United States

Clinical trials. Reimagined.

$6.0M raised
Jun 2023

Founder Contacts

30,000+ verified contacts

Southbank, Australia

Inosi Therapeutics develop therapies to address fibrosis.

$968K raised
Jun 2025

Founder Contacts

30,000+ verified contacts

New Suffolk, United States

ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

$1.0M raised
Jun 2024

Founder Contacts

30,000+ verified contacts

Angoulême, France

Inside Therapeutics offers microfluidic-based systems for nanoparticle manufacturing, focusing on LNP-RNA vaccine development and oncology.

$1.4M raised
Jun 2024

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Houdini Bio develops computational synthetic biology tools to redesign DNA constructs for improved genetic medicines.

$1.9M raised
Jun 2026

Founder Contacts

30,000+ verified contacts

Paris, France

Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities.

$3.1M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Paris, France

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

$2.2M raised
Jun 2023

Founder Contacts

30,000+ verified contacts

Vancouver, Canada

Cynaptec is a biopharmaceutical company focused on creating novel treatments for neurological and psychiatric conditions.

$6.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Cardiff, United Kingdom

Draig Therapeutics is a clinical-stage biopharmaceutical startup.

$140.0M raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Toronto, Canada

Microbiome-Derived Biotherapeutics

$256K raised
Jun 2025

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

Founded in 2022, we are a spin-out from Singapore-MIT Alliance for Research and Technology (SMART) and NTU Lee.

$1.0M raised
Jun 2024

Founder Contacts

30,000+ verified contacts

Edinburgh, United Kingdom

ŌGI Bio is a Biotechnology Research company.

$826K raised
Jun 2024

Founder Contacts

30,000+ verified contacts

Showing 151 to 175 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$32.2M
Total Funding Tracked
$804.0M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Boston
3 companies$30.6M
2.Vancouver
2 companies$106.0M
3.San Francisco
2 companies$29.0M
4.Paris
2 companies$5.3M
5.Montefiascone
1 companies$107K

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked